Abstract:The complex reservoir of metabolite-producing bacteria in the gastrointestinal tract contributes tremendously to human health and disease. Bacterial composition, and by extension gut metabolomic composition, is undoubtably influenced by the use of modern antibiotics. Herein, we demonstrate that polymyxin B, a last resort antibiotic, influences the production of the genotoxic metabolite colibactin from adherent-invasive Escherichia coli (AIEC) NC101. Colibactin can promote colorectal cancer through DNA double stranded breaks and interstrand cross-links. While the structure and biosynthesis of colibactin have been elucidated, chemical-induced regulation of its biosynthetic gene cluster and subsequent production of the genotoxin by E. coli are largely unexplored. Using a multiomic approach, we identified that polymyxin B stress enhances the abundance of colibactin biosynthesis proteins (Clb's) in multiple pks+ E. coli strains, including pro-carcinogenic AIEC, NC101; the probiotic strain, Nissle 1917; and the antibiotic testing strain, ATCC 25922. Expression analysis via qPCR revealed that increased transcription of clb genes likely contributes to elevated Clb protein levels in NC101. Enhanced production of Clb's by NC101 under polymyxin stress matched an increased production of the colibactin prodrug motif, a proxy for the mature genotoxic metabolite. Furthermore, E. coli with a heightened tolerance for polymyxin induced greater mammalian DNA damage, assessed by quantification of γH2AX staining in cultured intestinal epithelial cells. This study establishes a key link between the polymyxin B stress response and colibactin production in pks+ E. coli. Ultimately, our findings will inform future studies investigating colibactin regulation and the ability of seemingly innocuous commensal microbes to induce host disease.

In Vivo Evidence for a Prodrug Activation Mechanism During Colibactin Maturation

Critical Intermediates Reveal New Biosynthetic Events In The Enigmatic Colibactin Pathway

Comparative Metabolomics and Structural Characterizations Illuminate Colibactin Pathway-Dependent Small Molecules

Structural basis of the amidase ClbL central to the biosynthesis of the genotoxin colibactin

Two More Pieces of the Colibactin Genotoxin Puzzle from Escherichia Coli Show Incorporation of an Unusual 1-Aminocyclopropanecarboxylic Acid Moiety

ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli

Structure-Based Mechanistic Insights into ColB1, a Flavoprotein Functioning in-trans in the 2,2'-Bipyridine Assembly Line for Cysteine Dehydrogenation.

Identification of A Translocated Protein Segment in A Voltage-Dependent Channel

of the colibactin genotoxin puzzle from Escherichia coli show incorporation of an unusual 1-aminocyclopropanecarboxylic acid moiety †

A New Self-Immolative Colistin Prodrug with Dual Targeting Functionalities and Reduced Toxicity for the Treatment of Intracellular Bacterial Infections

Synthesis of colicin Ia neoglycoproteins: tools towards glyco-engineering of bacterial cell surfaces

Macrocyclic Colibactin Induces DNA Double-Strand Breaks Via Copper-Mediated Oxidative Cleavage

Functional Characterization and Crystal Structure of the Type II Peptidyl Carrier Protein ColA1a in Collismycins Biosynthesis†

Analysis of the Valgamicin Biosynthetic Pathway Reveals a General Mechanism for Cyclopropanol Formation across Diverse Natural Product Scaffolds

Directed Natural Product Biosynthesis Gene Cluster Capture and Expression in the Model Bacterium Bacillus Subtilis.

Coupling Novel Probes with Molecular Localization Microscopy Reveals Cell Wall Homeostatic Mechanisms in Staphylococcus Aureus

Evolution of Polymyxin Resistance Regulates Colibactin Production in Escherichia coli

Divergent Biosynthesis Yields a Cytotoxic Aminomalonate-Containing Precolibactin

Biosynthesis of Clorobiocin: Investigation of the Transfer and Methylation of the Pyrrolyl-2-carboxyl Moiety

Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster

Enhanced NADH Metabolism Involves Colistin-Induced Killing of Bacillus Subtilis and Paenibacillus Polymyxa.